Health
STAT+: Vertex kidney disease drug scrutinized for infection risk
Adam Feuerstein·STAT News·October 29, 2026
Ahead of its FDA approval decision on Nov 30, Vertex's kidney disease drug is being heavily scrutinized for infection risk.
Read the full story at STAT News →